Publications

Systematic Review
Journal Article Research Support, Non-U.S. Gov't
Epublish
Electronic publication date
April 8, 2024

View on Pubmed.gov 38576010 | View on doi.org 10.1186/s40478-...

Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.

Search for publications in this journal Acta Neuropathol Commun - 12(1):52

Abstract

The transcellular propagation of the aberrantly modified protein tau along the functional brain network is a key hallmark of Alzheimer's disease and related tauopathies. Inoculation-based tau propagation models can recapitulate the stereotypical spread of tau and reproduce various types of tau inclusions linked to specific tauopathy, albeit with varying degrees of fidelity. With this systematic review, we underscore the significance of judicious selection and meticulous functional, biochemical, and biophysical characterization of various tau inocula. Furthermore, we highlight the necessity of choosing suitable animal models and inoculation sites, along with the critical need for validation of fibrillary pathology using confirmatory staining, to accurately recapitulate disease-specific inclusions. As a practical guide, we put forth a framework for establishing a benchmark of inoculation-based tau propagation models that holds promise for use in preclinical testing of disease-modifying drugs.

References

Brain. 2013 Aug;136(Pt 8):2510-26

Acta Neuropathol. 2014 May;127(5):667-83

J Exp Med. 2016 Nov 14;213(12):2635-2654

J Neurosci. 2016 Apr 13;36(15):4351-61

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

© 2024. The Author(s).